Results 261 to 270 of about 17,745,525 (306)

G. vaginalis increases HSV-2 infection by decreasing vaginal barrier integrity and increasing inflammation in vivo. [PDF]

Front Immunol
Rahman N, Mian MF, Hayes CL, Nazli A, Kaushic C.   +4 more
europepmc   +1 more source

High prevalence and incidence of HSV-2 among people who inject drugs in Hai Phong, Vietnam, and risk factors associated with seroconversion. [PDF]

Eur J Clin Microbiol Infect Dis
D'Ottavi M, Scialabba I, Huong DT, Giang HT, Khue PM, Vinh VH, Vallo R, Michel L, Rapoud D, Quillet C, Thanh NTT, Bouniol J, Oanh KTH, Feelmyer J, Perre PV, Laureillard D, Jarlais DD, Nagot N, Molès JP.   +18 more
europepmc   +1 more source

Diagnosis and Management of Genital HSV-2

, 2012
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Development of a microneutralization assay for HSV-2

Journal of Virological Methods, 2021
Plaque Reduction Neutralization Test (PRNT) is the standard assay used for measuring neutralizing antibody responses to Herpes simplex virus type-2 (HSV-2). The PRNT is a cumbersome, time-consuming and laborious assay. The development of a faster, high throughput microneutralization assay (MNA) for HSV-2 viruses carried out in a 96-well format will ...
Melanie S. Horton, Michael Minnier, Scott Cosmi, Kara Cox, Jennifer Galli, Jessica Peters, Nicole Sullivan, Brian Squadroni, Aimin Tang, Arthur Fridman, Dai Wang, Zhifeng Chen, Kalpit A. Vora   +12 more
openaire   +2 more sources

HSV-2 transmission

Antiviral Research, 2004
A number of important risk factors for the acquisition of HSV-2 have been established including female gender, black or Hispanic ethnic origin, HIV infection, age, and increased number of sexual partners. Transmission is influenced by a number of biological factors such as sexual behavior, use of condoms, duration of relationships, and knowledge of a ...
S L, Sacks, P D, Griffiths, L, Corey, C, Cohen, A, Cunningham, G M, Dusheiko, S, Self, S, Spruance, L R, Stanberry, A, Wald, R J, Whitley   +10 more
openaire   +2 more sources

Modeling the synergy between HSV-2 and HIV and potential impact of HSV-2 therapy

Mathematical Biosciences, 2013
Mounting evidence indicates that genital HSV-2 infection may increase susceptibility to HIV infection and that co-infection may increase infectiousness. Accordingly, antiviral treatment of people with HSV-2 may mitigate the incidence of HIV in populations where both pathogens occur. To better understand the epidemiological synergy between HIV and HSV-2,
Feng, Zhilan, Qiu, Zhipeng, Sang, Zi, Lorenzo, Christina, Glasser, John   +4 more
openaire   +3 more sources

Seroprevalence of HSV-2 in Hungary and comparison of the HSV-2 prevalence of pregnant and infertile women

Acta Microbiologica et Immunologica Hungarica, 2008
Herpes simplex virus type 2 infection is a quite common but frequently asymptomatic, therefore undiagnosed condition. Genital HSV-2 infection may cause neonatal herpes, enhances HIV transmission and may play a role in infertility. To evaluate the prevalence of HSV-2 in Hungary we tested 2500 serum samples for the presence of anti-HSV-2 IgG by ELISA ...
Hettmann, Andrea, Gerle, Borbála, Barcsay, Erzsébet, Csiszár, Csenge, Takács, Mária   +4 more
openaire   +3 more sources

Psychosocial Impact of a Positive HSV‐2 Diagnosis on Adults with Unrecognized HSV‐2 Infection

Public Health Nursing, 2011
ABSTRACT Objective: To evaluate the current research on the psychosocial impact of a positive herpes simplex virus type 2 (HSV‐2) diagnosis on asymptomatic adults.Design and Sample: A structured review of PubMed, CINAHL, and MEDLINE resulted in 8 articles published between 2000 and 2008.Measures: Articles were included if they investigated ...
Allison, Provenzale, Kara, Evans, Julie, Russell, Tammy, Hoory, Hayley, Mark   +4 more
openaire   +2 more sources

Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons

Vaccine, 2011
HSV-2, the primary causative agent of genital herpes, establishes latency in sensory ganglia and reactivates causing recurrent lesions and viral shedding. Induction or expansion of CD4(+) and CD8(+) T cell responses are expected to be important for a successful therapeutic vaccine against HSV-2.
Anna, Wald, David M, Koelle, Kenneth, Fife, Terri, Warren, Kenneth, Leclair, Roman M, Chicz, Stephen, Monks, Daniel L, Levey, Cristina, Musselli, Pramod K, Srivastava   +9 more
openaire   +2 more sources